Table 3.

Associations Between Patient Activation and HIV Clinical Outcomes Among Patients Prescribed Antiretroviral Therapy* (n = 411)

	CD4 > 200 cells/mL3	Adherence†	Viral suppression	Viral suppression
			Model A	Model B
	aOR (95 % CI)	aOR (95 % CI)	aOR (95 % CI)	aOR (95 % CI)
5-point change in PAM score	1.10 (1.01, 1.21)	1.18 (1.09, 1.29)	1.08 (1.00, 1.17)	1.04 (0.96, 1.13)
	p = 0.032	P < 0.001	p = 0.046	p = 0.309

*All models adjusted for gender, age, race, education, literacy, self-perceived social status, alcohol abuse, illicit drug use, depression, site, and clustering by provider

†Defined as “takes antiretroviral medications as prescribed about 100 % of time” vs. less than 100 % of time.

Model A: adjusted for above, but not adherence

Model B: adjusted for above, with adherence added to model

aOR = adjusted odds ratio, PAM = patient activation measure score